{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:01:24Z","timestamp":1784368884943,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Most of the palliative care (PC) patients have oncologic diseases, being hematologic tumors a small part of them. According to the literature, onco-hematologic (OH) patients should be individualized from those with solid tumors for the specialized care required along their disease course. This study aims to review the casuistry of OH patients referred to PC in a specialized oncologic hospital and help to understand better how hematologists can improve the care of these patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We analyzed all OH patients referred to the PC service in 1 oncologic hospital along 42 months, through consultation of their clinical files.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 179 patients were reviewed (52.% males, median age of 71 years): 48.6% had non-Hodgkin lymphoma, 26.3% had multiple myeloma, 10.6% had acute leukemia, 14.5% had other OH diseases; 88.2% were treated for their OH disease (96.2% with chemotherapy, 28.5% radiotherapy, and 21.5% hematopoietic stem cell transplant). The referral was heterogeneous among physicians (27.4% by 1 physician). Most patients were firstly observed as inpatients (55.3%) and 17.9% in the outpatient consult. At the end of the study, 98.9% of the patients died (88.7% in the hospital, 10.2% at home). The median time between the end of treatment and referral do PC was 46 days and between referral and death was 16 days. We also reviewed medical prescription in the last month of life and we noticed that most invasive orders were requested by hematologists (as antibiotic prescription, imaging, and biopsy studies).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Significance of results:<\/jats:title>\n            <jats:p>This study demonstrated that OH patients should be referred earlier to PC and that a more intensive team work needs to be practiced between PC and hematologists. More educational programs for healthcare workers on this issue are needed in order to guarantee a more effective assistance in the appropriate time.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.pbj.0000000000000039","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T20:38:18Z","timestamp":1572899898000},"page":"e39","source":"Crossref","is-referenced-by-count":3,"title":["The profile of the onco-hematology patient in the palliative care: 4 years of experience"],"prefix":"10.1097","volume":"4","author":[{"given":"Maria Eduarda","family":"Couto","sequence":"first","affiliation":[{"name":"Onco-Hematology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Onco-Hematology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio","family":"Mariz","sequence":"additional","affiliation":[{"name":"Onco-Hematology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ferraz Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Palliative Care Service, Instituto Portugu\u00eas de Oncologia do Porto FG, EPE, Porto, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/asheducation-2015.1.471","article-title":"When and why should patients with hematologic malignancies see a palliative care specialist?","volume":"2015","author":"LeBlanc","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Prog."},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/jpm.2017.0097","article-title":"Access to palliative care consultation and advance care planning for adults with high-risk leukemia","volume":"21","author":"Freeman","year":"2017","journal-title":"J Palliat Med."},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0269216310391692","article-title":"Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data","volume":"25","author":"Howell","year":"2011","journal-title":"Palliat Med."},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/cncr.28614","article-title":"Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study","volume":"120","author":"Hui","year":"2014","journal-title":"Cancer."},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00277-010-1057-3","article-title":"Palliative care for patients with hematological malignancies\u2014a case series","volume":"90","author":"Alt-Epping","year":"2011","journal-title":"Ann Hematol."},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpainsymman.2014.07.003","article-title":"What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network","volume":"49","author":"LeBlanc","year":"2015","journal-title":"J Pain Symptom Manage."},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpainsymman.2013.12.159","article-title":"Palliative care for patients with hematologic malignancies: a profile of patients with blood cancers referred to the CHOICE Hospice Network","volume":"47","author":"LeBlanc","year":"2014","journal-title":"J Pain Symptom Manage."},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmjspcare-2016-001289","article-title":"Determinants of hospital death in haematological cancers: findings from a qualitative study","volume":"8","author":"McCaughan","year":"2018","journal-title":"BMJ Support Palliat Care."},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","article-title":"Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?","volume":"26","author":"Earle","year":"2008","journal-title":"J Clin Oncol."},{"key":"R10-20230824","article-title":"Supporting palliative care","year":"2016","journal-title":"Ash Clin News."},{"key":"R11-20230824","article-title":"Palliative care: time for hematology to step up","year":"2015","journal-title":"Ash Clin News."},{"key":"R12-20230824","first-page":"7","article-title":"End of life care in hematology: still a challenging concern","volume":"3","author":"Niscola","year":"2014","journal-title":"Ann Palliat Med."},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1634\/theoncologist.2015-0240","article-title":"Attitudes and beliefs toward supportive and palliative care referral among hematologic and solid tumor oncology specialists","volume":"20","author":"Hui","year":"2015","journal-title":"Oncologist."},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"E230","DOI":"10.1200\/JOP.2014.001859","article-title":"Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study","volume":"11","author":"LeBlanc","year":"2015","journal-title":"J Oncol Pract."},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JOP.2013.000896","article-title":"Practical issues in palliative and quality-of-life care","volume":"9","author":"Hennessy","year":"2013","journal-title":"J Oncol Pract."},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/jpm.2009.0267","article-title":"Palliative care and the hemato-oncological patient: can we live together? A review of the literature","volume":"13","author":"Manitta","year":"2010","journal-title":"J Palliat Med."},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3747\/co.23.3404","article-title":"Early integration of palliative care into standard oncology care: evidence and overcoming barriers to implementation","volume":"23","author":"Kain","year":"2016","journal-title":"Curr Oncol."},{"issue":"(suppl)","key":"R18-20230824","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/jco.2015.33.29_suppl.40","article-title":"Exploring the preferences for place of death among cancer patients and their family caregivers","volume":"33","author":"Vidal","year":"2015","journal-title":"J Clin Oncol."},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11899-017-0392-z","article-title":"Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve?","volume":"12","author":"LeBlanc","year":"2017","journal-title":"Curr Hematol Malig Rep."},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1200\/JOP.2014.000968","article-title":"Palliative care and hematologic malignancies: old dog, new tricks?","volume":"10","author":"LeBlanc","year":"2014","journal-title":"J Oncol Pract."}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:49:02Z","timestamp":1692841742000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/j.pbj.0000000000000039","relation":{},"ISSN":["2444-8664"],"issn-type":[{"value":"2444-8664","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]}}}